[Dronedarone--a new therapeutic option for controlling atrial rhythm and ventricular frequency].
Klein
H H
HH
Medizinische Klinik II (Schwerpunkt Kardiologie) des Klinikums Idar-Oberstein GmbH.
D000638:Amiodarone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001281:Atrial Fibrillation / Q000188:drug therapy*; D016275:Atrial Function / Q000187:drug effects*; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D000077764:Dronedarone; D004594:Electrophysiology; D006801:Humans; D055502:Secondary Prevention; D016276:Ventricular Function / Q000187:drug effects*
D000889:Anti-Arrhythmia Agents; D003404:Creatinine; D000077764:Dronedarone; D000638:Amiodarone